.svg)
ZIM Laboratories Limited Receives Marketing Authorization (MA) for Dimethyl Fumarate (120 mg & 240 mg) Modified Release Capsules in Portugal, Europe
ZIM Laboratories Limited Announces Grant of Marketing Authorization for Azithromycin for Oral Suspension 200 mg/5ml (40 mg/ml) in Portugal, Europe.
ZIM Laboratories Limited has been granted marketing authorization for Sildenafil 50 mg ODS by AEMPS.
Zim Laboratories Limited has been granted marketing rights for Rizatriptan by Infarmed, for its European subsidiaries.
ViewZIM Laboratories Limited and Hypera Pharma Group enter into an exclusive licensing agreement of Vitamin D3 Orally Disintegrating Strips.
View
